EarningsQ4 2025 Earnings Report

BioMarin Pharmaceutical (BMRN) Q4 2025 Earnings Report

0 Followers

MX:BMRN Q4 2025 EPS Results

Actual EPS-$4.34

Consensus EPS$3.05

Beat/MissMissed by -$7.39

One Year Ago EPS$11.57

Actual Revenue$16.18B

Expected Revenue$15.07B

Beat/MissBeat by +$1.11B

YoY Revenue Growth+21.24%

QuarterQ4 2025

Date02/23/2026

TimeAfter Close

Conference CallMonday, February 23, 2026

MX:BMRN Upcoming Earnings

BioMarin Pharmaceutical's next earnings date is estimated for November 3, 2026, based on past reporting schedules.

MX:BMRN Q4 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 03, 2026	2026 (Q3)	24.07 / -	-2.892	―
Aug 06, 2026	2026 (Q2)	17.12 / 21.69	22.23	-2.44% (-0.54)
May 04, 2026	2026 (Q1)	12.51 / 13.74	17.17	-20.00% (-3.43)
Feb 23, 2026	2025 (Q4)	3.05 / -4.34	11.567	-137.50% (-15.90)
Oct 27, 2025	2025 (Q3)	-5.06 / -2.89	9.94	-129.09% (-12.83)
Aug 04, 2025	2025 (Q2)	15.56 / 22.23	9.94	123.64% (+12.29)
May 01, 2025	2025 (Q1)	12.90 / 17.17	8.314	106.52% (+8.86)
Feb 19, 2025	2024 (Q4)	9.65 / 11.57	1.988	481.82% (+9.58)
Oct 29, 2024	2024 (Q3)	9.60 / 9.94	3.795	161.90% (+6.14)
Aug 05, 2024	2024 (Q2)	6.47 / 9.94	5.241	89.66% (+4.70)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed